Exp (B) | 95% CI for Exp (B) | p | |
---|---|---|---|
Age | |||
≤ 55 years | 1 | ||
> 55 years | 1.138 | 0.713–1.816 | 0.589 |
Sex | |||
Female | 1 | ||
Male | 1.037 | 0.653–1.648 | 0.877 |
Main tumor size | |||
≤ 2 cm | 1 | ||
> 2 cm | 1.689 | 1.068–2.671 | 0.025 |
Skip metastasis | |||
No | 1 | ||
Yes | 0.696 | 0.392–1.235 | 0.215 |
LN ratio (central) | |||
≤ 0.44 | 1 | ||
> 0.44 | 2.492 | 1.508–4.118 | < 0.001 |
LN ratio (lateral) | |||
≤ 0.29 | 1 | ||
> 0.29 | 2.822 | 1.799–4.426 | < 0.001 |
MRND type | |||
Ipsilateral | 1 | ||
Bilateral | 2.158 | 1.267–3.676 | 0.004 |
Multifocality | |||
No | 1 | ||
Yes | 1.735 | 1.131–2.662 | 0.012 |
Bilaterality | |||
No | 1 | ||
Yes | 1.514 | 0.981–2.337 | 0.061 |
CLT | |||
NO | 1 | ||
Yes | 0.542 | 0.305–0.962 | 0.037 |
ETE | |||
No/minor | 1 | ||
Gross | 1.583 | 1.022–2.453 | 0.040 |
LVI | |||
No | 1 | ||
Yes | 1.097 | 0.444–2.708 | 0.841 |
Stage | |||
I | 1 | ||
II | 0.952 | 0.548–1.654 | 0.862 |
III | 1.740 | 0.863–3.509 | 0.122 |